TME Pharma N.V.
LEI 724500EPNADXWZ58U595
This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings for this company, out of 28. Reading the whole list, and the filer page behind every line, is part of the subscription. So are the insider, quant and timing scores for this company, the price beside each line, the price history with every buy marked on it, the moments when several insiders bought within ninety days, and following this company. What that costs is on the pricing page.
The most recent filings
5 of 28Most recent trade first. Reported is the day the filing reached the AFM, usually a few days after the trade itself, so that column runs slightly out of step. On an award the register reports a price of 0: nothing was paid, and the Quantity column shows the size.
| Filed by | Transaction | Reported |
|---|---|---|
| Ouden, van den D.M.Managing Director / Chief Executive Officer | Open-market sell€170,000quantity 1,000,000 | Aug 28, 2026 |
| Ouden, van den D.M.Managing Director / Chief Executive Officer | Open-market sell€140,000quantity 1,000,000 | Aug 27, 2026 |
| Ouden, van den D.M.Managing Director / Chief Executive Officer | Open-market sell€23,645quantity 214,950 | Aug 27, 2026 |
| Ouden, van den D.M.Managing Director/CEO | Open-market sell€50,606quantity 460,050 | Aug 25, 2026 |
| van den Ouden DMManaging Director / Chief Executive Officer | Open-market buy€13,500quantity 135,000 | Sep 30, 2025 |